Details for New Drug Application (NDA): 018731
✉ Email this page to a colleague
The generic ingredient in BUSPAR is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Summary for 018731
Tradename: | BUSPAR |
Applicant: | Bristol Myers Squibb |
Ingredient: | buspirone hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018731
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 29, 1986 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 29, 1986 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Apr 22, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 018731
Complete Access Available with Subscription